ACM Research, Inc.
ACM Research, Inc. (ACMR) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for ACM Research, Inc. (ACMR), featuring income statements, balance sheets, and cash flow data.
ACM Research, Inc. (ACMR) Income Statement & Financial Overview
Review ACM Research, Inc. ACMR income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $172.35M | $223.47M | $203.98M | $202.48M |
| Cost of Revenue | $89.80M | $112.66M | $99.14M | $105.70M |
| Gross Profit | $82.55M | $110.81M | $104.83M | $96.78M |
| Gross Profit Ratio | $0.48 | $0.50 | $0.51 | $0.48 |
| R&D Expenses | $27.50M | $27.75M | $27.84M | $25.97M |
| SG&A Expenses | $29.27M | $39.08M | $32.81M | $33.22M |
| Operating Expenses | $56.77M | $66.83M | $60.65M | $59.19M |
| Total Costs & Expenses | $146.57M | $179.48M | $159.79M | $164.89M |
| Interest Income | $3.34M | $2.81M | $2.97M | $2.38M |
| Interest Expense | $1.56M | $1.23M | $1.21M | $932000.00 |
| Depreciation & Amortization | $3.02M | $2.89M | $2.39M | $2.21M |
| EBITDA | $25.78M | $60.55M | $46.28M | $39.84M |
| EBITDA Ratio | $0.15 | $0.27 | $0.23 | $0.20 |
| Operating Income | $25.78M | $43.99M | $44.18M | $37.59M |
| Operating Income Ratio | $0.15 | $0.20 | $0.22 | $0.19 |
| Other Income/Expenses (Net) | $1.39M | $12.44M | -$1.50M | $3.14M |
| Income Before Tax | $27.17M | $56.42M | $42.68M | $40.73M |
| Income Before Tax Ratio | $0.16 | $0.25 | $0.21 | $0.20 |
| Income Tax Expense | $2.15M | $17.32M | $4.007M | $9.34M |
| Net Income | $20.38M | $31.08M | $30.90M | $24.21M |
| Net Income Ratio | $0.12 | $0.14 | $0.15 | $0.12 |
| EPS | $0.32 | $0.49 | $0.49 | $0.39 |
| Diluted EPS | $0.30 | $0.46 | $0.46 | $0.35 |
| Weighted Avg Shares Outstanding | $63.27M | $62.79M | $62.50M | $62.18M |
| Weighted Avg Shares Outstanding (Diluted) | $66.95M | $66.52M | $66.67M | $67.06M |
Financial performance has remained strong, with revenue growing from $202.48M in Q2 2024 to $172.35M in Q1 2025. Gross profit continued to perform well, with margins at 48% in the latest quarter. Operating income reached $25.78M in Q1 2025, holding a steady 15% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $25.78M. Net income dropped to $20.38M, keeping EPS at $0.32. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan